Association of APOE polymorphisms with disease severity in MS is limited to women

O. H. Kantarci, D. D. Hebrink, S. J. Achenbach, S. J. Pittock, A. Altintas, J. L. Schaefer-Klein, E. J. Atkinson, M. De Andrade, C. T. McMurray, M. Rodriguez, Brian G. Weinshenker

Research output: Contribution to journalArticle

69 Scopus citations

Abstract

The authors studied the association of an exon 4 (E4*ε2/3/4) and three promoter polymorphisms of APOE with disease course and severity stratified by gender in 221 patients with multiple sclerosis from two overlapping population-based prevalence cohorts. Women carriers of the E4*ε2 allele took longer to attain an Expanded Disability Status Scale score of 6 (p = 0.015) and had more favorable ranked severity scores than noncarriers (p = 0.009). There was no association in men. Alleles ε3 or ε4 and promoter polymorphisms were not associated with disease course or severity.

Original languageEnglish (US)
Pages (from-to)811-814
Number of pages4
JournalNeurology
Volume62
Issue number5
DOIs
StatePublished - Mar 9 2004

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Association of APOE polymorphisms with disease severity in MS is limited to women'. Together they form a unique fingerprint.

  • Cite this

    Kantarci, O. H., Hebrink, D. D., Achenbach, S. J., Pittock, S. J., Altintas, A., Schaefer-Klein, J. L., Atkinson, E. J., De Andrade, M., McMurray, C. T., Rodriguez, M., & Weinshenker, B. G. (2004). Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology, 62(5), 811-814. https://doi.org/10.1212/01.WNL.0000113721.83287.83